Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer

Background: We studied the combination of pemetrexed, a multi-targeted antifolate, and cetuximab, an mAb against the epidermal growth factor receptor, with radiotherapy in poor prognosis head and neck cancer. Patients and methods: Patients received pemetrexed on days 1, 22, and 43 on a dose-escalati...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Argiris, A., Karamouzis, M. V., Smith, R., Kotsakis, A., Gibson, M. K., Lai, S. Y., Kim, S., Branstetter, B. F., Shuai, Y., Romkes, M., Wang, L., Grandis, J. R., Ferris, R. L., Johnson, J. T., Heron, D. E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2011
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3200222/
https://ncbi.nlm.nih.gov/pubmed/21363880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdr002
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi